miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor

Published in: Biochemical and Biophysical Research Communications

Volume 406, Issue 4, pp. 518-523

DOI: 10.1016/j.bbrc.2011.02.065